(Reuters) - Becton Dickinson said on Thursday the U.S. Food and Drug Administration (FDA) cleared its finger-prick blood collection device that could provide a less-invasive option for some commonly ordered lab tests.
The device, BD MiniDraw Collection System, can help collect blood samples from a patient's finger through a trained healthcare professional without the need to do it from a vein, the company said.
The clearances include blood collection for commonly ordered lab tests such as for lipid panel and tests to diagnose and monitor a variety of chronic conditions from hypertension to high cholesterol, it said.
(Reporting by Mariam Sunny in Bengaluru; Editing by Anil D'Silva and Sriraj Kalluvila)
Reuters Health Information © 2023
